115 related articles for article (PubMed ID: 6927953)
1. Acute myelogenous leukemia and hepatitis.
Cacciola E; Giustolisi R
Ann Intern Med; 1980 Jan; 92(1):127-8. PubMed ID: 6927953
[No Abstract] [Full Text] [Related]
2. Advances in the management of adult acute myelogenous leukaemia.
Whittaker JA
Br Med J; 1980 Oct; 281(6246):960-4. PubMed ID: 7000284
[No Abstract] [Full Text] [Related]
3. [Hepatitic complications and transfusional support in the remission-induction treatment of acute myeloid leukemia. Clinical study of l22 cases].
Orlandi E; Alessandrino EP; Pagnucco G; Bernasconi C
Riv Emoter Immunoematol; 1985; 32(1):41-9. PubMed ID: 3866290
[No Abstract] [Full Text] [Related]
4. Beneficial effects of hepatitis in patients with acute myelogenous leukemia.
Barton JC; Conrad ME
Ann Intern Med; 1979 Feb; 90(2):188-90. PubMed ID: 286572
[TBL] [Abstract][Full Text] [Related]
5. Posttransfusion hepatitis in acute myelogenous leukemia.
Novak RW
JAMA; 1981 Jul; 246(3):215-6. PubMed ID: 6941034
[No Abstract] [Full Text] [Related]
6. [Acute lymphatic leukemia in adults. Therapy and prognosis in comparison with acute myelogenous leukemia].
Abbrederis K; Michlmayr G; Schmalzl F
Med Klin; 1974 Mar; 69(10):427-31. PubMed ID: 4524609
[No Abstract] [Full Text] [Related]
7. Transfusion transmission of hepatitis A virus with fecal shedding in a previously hepatitis A vaccinated recipient.
Vestergaard HT; Harritshøj LH; Midgley SE; Ullum H; Kampmann P
J Infect Chemother; 2018 Sep; 24(9):766-768. PubMed ID: 29490881
[TBL] [Abstract][Full Text] [Related]
8. Stratification of de novo adult acute myelogenous leukemia with adverse-risk karyotype: can we overcome the worse prognosis of adverse-risk group acute myelogenous leukemia with hematopoietic stem cell transplantation?
Yoon JH; Kim HJ; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Biol Blood Marrow Transplant; 2014 Jan; 20(1):80-8. PubMed ID: 24149098
[TBL] [Abstract][Full Text] [Related]
9. Letter: Cytomegalovirus in non-B post-transfusion hepatitis.
Fiala M; Nelson RJ; Myhre BA; Guze LB; Overby LR; Ling CM
Lancet; 1974 Nov; 2(7890):1206-7. PubMed ID: 4139618
[No Abstract] [Full Text] [Related]
10. [Leukapheresis of patients with acute leukemia and chronic myelogenous leukemia (author's transl)].
Kawashima K; Ueda R
Rinsho Ketsueki; 1977 May; 18(5):620-6. PubMed ID: 269295
[No Abstract] [Full Text] [Related]
11. [General strategy for acute myelogenous leukaemia therapy (author's transl)].
Fernández-Rañada J; Escudero A; Vázquez L; Gómez-Reino F; Fernández-Villalta MJ; Fernández de Pivel D; Merino JL; Olmeda F
Sangre (Barc); 1981; 26(5B):855-66. PubMed ID: 7034245
[No Abstract] [Full Text] [Related]
12. Long-term survival in acute myelogenous leukemia complicated by chronic active hepatitis.
Rotoli B; Formisano S; Martinelli V; Nigro M
N Engl J Med; 1982 Dec; 307(27):1712-3. PubMed ID: 6958976
[No Abstract] [Full Text] [Related]
13. Transmission of infectious mononucleosis by transfusion of pre-illness plasma.
Turner AR; MacDonald RN; Cooper BA
Ann Intern Med; 1972 Nov; 77(5):751-3. PubMed ID: 4343078
[No Abstract] [Full Text] [Related]
14. [Risk of transfusion-associated non-A, non-B hepatitis in the treatment of hematologic malignancy].
Gruber A; Björkholm M; Akerblom O; Christensson M
Lakartidningen; 1990 Aug; 87(34):2570-2. PubMed ID: 2120523
[No Abstract] [Full Text] [Related]
15. Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.
Leisch M; Weiss L; Lindlbauer N; Jungbauer C; Egle A; Rohde E; Greil R; Grabmer C; Pleyer L
Leuk Res; 2017 Aug; 59():12-19. PubMed ID: 28535394
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic complications in acute myelogenous leukemia.
Gale RP
N Engl J Med; 1979 Sep; 301(10):558. PubMed ID: 287863
[No Abstract] [Full Text] [Related]
17. Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients.
Sánchez-Quijano A; Pineda JA; Lissen E; Leal M; Díaz-Torres MA; García De Pesquera F; Rivera F; Castro R; Muñoz J
Lancet; 1988 Jun; 1(8597):1245-9. PubMed ID: 2897517
[TBL] [Abstract][Full Text] [Related]
18. Distinctive acral erythema occurring during therapy for severe myelogenous leukemia.
Levine LE; Medenica MM; Lorincz AL; Soltani K; Raab B; Ma A
Arch Dermatol; 1985 Jan; 121(1):102-4. PubMed ID: 3855356
[TBL] [Abstract][Full Text] [Related]
19. Long survival in two cases of acute myelogenous leukemia complicated by chronic active hepatitis.
Rotoli B; Formisano S; Martinelli V; Nigro M
Haematologica; 1983; 68(6):797-804. PubMed ID: 6421674
[No Abstract] [Full Text] [Related]
20. Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice.
Lee EM; Yee D; Busfield SJ; McManus JF; Cummings N; Vairo G; Wei A; Ramshaw HS; Powell JA; Lopez AF; Lewis ID; McCall MN; Lock RB
Haematologica; 2015 Jul; 100(7):914-26. PubMed ID: 26130514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
